Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-07-17MLYS144Rodman David Malcom plan to sell securities of Mineralys Therapeutics, Inc. under Form 144MEDIUM
Rodman David Malcom filed Form 144 to notify SEC of plan to sell 416 units of Mineralys Therapeutics, Inc. securities around 2026-07-17, with aggregate market value of $11,016.30. The total outstanding units is 82498101.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in...
Mid CapBiotechnology
2026-07-17MNKD144DAVID THOMSON plan to sell securities of MannKind Corporation under Form 144MEDIUM
DAVID THOMSON filed Form 144 to notify SEC of plan to sell 24109 units of MannKind Corporation securities around 2026-07-17, with aggregate market value of $97,400.36. The total outstanding units is 308950166.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 mon...
Small CapBiotechnology
2026-07-16ADPT144SUSAN BOBULSKY plan to sell securities of ADAPTIVE BIOTECHNOLOGIES CORPORATION under Form 144MEDIUM
SUSAN BOBULSKY filed Form 144 to notify SEC of plan to sell 5000 units of ADAPTIVE BIOTECHNOLOGIES CORPORATION securities around 2026-07-16, with aggregate market value of $114,500.00. The total outstanding units is 160044392.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transacti...
Mid CapBiotechnology
2026-07-16Adaptive Biotechnologies Corp144SUSAN BOBULSKY plan to sell securities of ADAPTIVE BIOTECHNOLOGIES CORPORATION under Form 144DuplicateMEDIUM
SUSAN BOBULSKY filed Form 144 to notify SEC of plan to sell 5000 units of ADAPTIVE BIOTECHNOLOGIES CORPORATION securities around 2026-07-16, with aggregate market value of $114,500.00. The total outstanding units is 160044392.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transacti...
Mid CapBiotechnology